Inadequate Dosage of Mycophenolate Mofetil Is Likely to Yield Substandard Trial Results and Substandard Patient Care
- PMID: 34028501
- DOI: 10.1001/jamapediatrics.2021.1074
Inadequate Dosage of Mycophenolate Mofetil Is Likely to Yield Substandard Trial Results and Substandard Patient Care
Comment in
-
Inadequate Dosage of Mycophenolate Mofetil Is Likely to Yield Substandard Trial Results and Substandard Patient Care-Reply.JAMA Pediatr. 2021 Aug 1;175(8):870-871. doi: 10.1001/jamapediatrics.2021.1068. JAMA Pediatr. 2021. PMID: 34028511 No abstract available.
Comment on
-
Rituximab vs Low-Dose Mycophenolate Mofetil in Recurrence of Steroid-Dependent Nephrotic Syndrome in Children and Young Adults: A Randomized Clinical Trial.JAMA Pediatr. 2021 Jun 1;175(6):631-632. doi: 10.1001/jamapediatrics.2020.6150. JAMA Pediatr. 2021. PMID: 33616641 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources